lenti-Cas9-sgHPRT1 Citations (2)

Originally described in: CRISPR/Cas9 screening using unique molecular identifiers.
Schmierer B, Botla SK, Zhang J, Turunen M, Kivioja T, Taipale J Mol Syst Biol. 2017 Oct 9;13(10):945. doi: 10.15252/msb.20177834. PubMed Journal

---

Articles Citing lenti-Cas9-sgHPRT1

Articles
Network-based elucidation of colon cancer drug resistance mechanisms by phosphoproteomic time-series analysis. Rosenberger G, Li W, Turunen M, He J, Subramaniam PS, Pampou S, Griffin AT, Karan C, Kerwin P, Murray D, Honig B, Liu Y, Califano A. Nat Commun. 2024 May 9;15(1):3909. doi: 10.1038/s41467-024-47957-3. PubMed
Identification and Pharmacological Targeting of Treatment-Resistant, Stem-like Breast Cancer Cells for Combination Therapy. Worley J, Noh H, You D, Turunen MM, Ding H, Paull E, Griffin AT, Grunn A, Zhang M, Guillan K, Bush EC, Brosius SJ, Hibshoosh H, Mundi PS, Sims P, Dalerba P, Dela Cruz FS, Kung AL, Califano A. bioRxiv [Preprint]. 2024 May 16:2023.11.08.562798. doi: 10.1101/2023.11.08.562798. PubMed

If you have published an article using this material, please email us at to have your article added to this page.